Egetis Therapeutics AB

NEW
OSTO:EGTX (Sweden)  
kr 7.33 +0.53 (+7.79%) Aug 21
At Loss
P/B:
11.65
Market Cap:
kr 3.41B ($ 360.17M)
Enterprise V:
kr 3.09B ($ 327.01M)
Volume:
1.52M
Avg Vol (2M):
660.43K
Trade In:
Volume:
1.52M
At Loss
Avg Vol (2M):
660.43K

Egetis Therapeutics AB (OSTO:EGTX) Dividend

Egetis Therapeutics AB (OSTO:EGTX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -22.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: OSTO:EGTX Dividend

Does Egetis Therapeutics AB (OSTO:EGTX) pay a dividend?

Egetis Therapeutics AB (OSTO:EGTX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Egetis Therapeutics AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Egetis Therapeutics AB has returned capital to shareholders via buybacks at a rate of -22.6% over the past 3 years.

What are dividend-paying alternatives to Egetis Therapeutics AB?

For dividend-paying alternatives in Egetis Therapeutics AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.